B-cell subsets and platelet counts in HIV-1 seropositive subjects
- PMID: 1376384
- DOI: 10.1016/0140-6736(92)92033-c
B-cell subsets and platelet counts in HIV-1 seropositive subjects
Abstract
A subset of B lymphocytes positive for the CD5 antigen have been implicated in several autoimmune disorders. To investigate their role in human immunodeficiency virus type 1 (HIV-1) infection, we studied peripheral-blood B and T lymphocytes from HIV-1-positive patients with (n = 13) and without (n = 18) thrombocytopenia, 8 patients with classic autoimmune thrombocytopenia, and 16 healthy controls. The proportion of CD5-positive B cells was significantly higher in the HIV-1-positive thrombocytopenic patients than in the healthy controls, as a result of both higher numbers of CD5-positive B cells and lower numbers of CD5-negative B cells. Platelet count was positively correlated with CD5-negative B-cell count (r = 0.6, p less than 0.001) and negatively correlated with proportion of B cells that were CD5 positive (r = -0.5, p less than 0.01) among the HIV-1-positive patients. The high concentrations of IgM-containing immune complexes in HIV-1-positive patients with autoimmune disorders may be due to changes in the CD5-positive B-cell subset.
Similar articles
-
CD5+ B lymphocytes in HIV infection: relationship to immunological progression of disease.Clin Immunol Immunopathol. 1993 Mar;66(3):260-8. doi: 10.1006/clin.1993.1034. Clin Immunol Immunopathol. 1993. PMID: 7679344
-
The relationship between CD5+ and CD5- B cells, immunoglobulin-secreting cells (IgSC), and CD4 T cells in human immunodeficiency virus (HIV) infection.Ann N Y Acad Sci. 1992 May 4;651:591-3. doi: 10.1111/j.1749-6632.1992.tb24672.x. Ann N Y Acad Sci. 1992. PMID: 1376087 No abstract available.
-
[CD5+B cells and autoimmune diseases].Zhonghua Nei Ke Za Zhi. 1994 Sep;33(9):590-2. Zhonghua Nei Ke Za Zhi. 1994. PMID: 7536147 Chinese.
-
Human CD5-positive B cells in lymphoid malignancy and connective tissue diseases.Eur J Clin Invest. 1993 Mar;23(3):139-50. doi: 10.1111/j.1365-2362.1993.tb00753.x. Eur J Clin Invest. 1993. PMID: 7682953 Review.
-
CD5 as a Target for Immune-Based Therapies.Crit Rev Immunol. 2015;35(2):85-115. doi: 10.1615/critrevimmunol.2015013532. Crit Rev Immunol. 2015. PMID: 26351145 Review.
Cited by
-
Bovine leukemia virus-induced lymphocytosis and increased cell survival mainly involve the CD11b+ B-lymphocyte subset in sheep.J Virol. 1998 May;72(5):4413-20. doi: 10.1128/JVI.72.5.4413-4420.1998. J Virol. 1998. PMID: 9557733 Free PMC article.
-
Reduced proviral loads during primo-infection of sheep by Bovine Leukemia virus attenuated mutants.Retrovirology. 2004 Oct 5;1:31. doi: 10.1186/1742-4690-1-31. Retrovirology. 2004. PMID: 15462678 Free PMC article.
-
The nature of the autoimmune antibody repertoire in human immunodeficiency virus type 1 infection.Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3710-4. doi: 10.1073/pnas.91.9.3710. Proc Natl Acad Sci U S A. 1994. PMID: 8170974 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources